ArticleBreast cancer research and treatment2026

Comparing infectious risk of Trastuzumab-deruxtecan to Trastuzumab-emtansine in patients with breast cancer.

Scott Gayfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.